Last reviewed · How we verify
NCT04856878: VanCat
Effect of Vancomycin After Catheter Replacement
Phase 4 trial testing Vancomycin in Central Line-associated Bloodstream Infection (CLABSI) in 100 participants. Status unknown.
30 June 2024
Quick facts
| Lead sponsor | University of Zurich |
|---|---|
| Phase | Phase 4 |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 100 |
| Start date | 1 June 2021 |
| Primary completion | 30 June 2024 |
| Estimated completion | 31 December 2024 |
Drugs / interventions tested
- Vancomycin (vancomycin) — full drug profile →
Conditions studied
- Central Line-associated Bloodstream Infection (CLABSI) — all drugs for Central Line-associated Bloodstream Infection (CLABSI) →
- Catheter-related Bloodstream Infection — all drugs for Catheter-related Bloodstream Infection →
Sponsor
University of Zurich
Who can join
18 and older, any sex, with Central Line-associated Bloodstream Infection (CLABSI) or Catheter-related Bloodstream Infection. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Randomized controlled trial of the effect of a single-dose intravenous Vancomycin after catheter replacement for suspected central line-associated bloodstream infection on resolution of infection in critically ill patients.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04856878
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Vancomycin
Trials testing the same drug.
- NCT07435051 — Prospective, Randomized, Multicenter Clinical Trial of Bisphosphonates Combined With Vancomycin for the Treatment of Cie · Phase 3 · not yet recruiting
- NCT06567808 — Prevention of Infections in Cardiac Surgery (PICS): a Cluster-randomized Factorial Cross-over Trial · Phase 4 · not yet recruiting
- NCT06702345 — Clostridioides Difficile Controlled Human Infection Model · NA · not yet recruiting
- NCT06716749 — Effectiveness of Adding Morphine to Intraosseous Vancomycin for Pain Control in Total Knee Arthroplasty · Phase 2 · completed
- NCT06439953 — Irrisept Solution for Instrumented Spine Surgery · NA · recruiting
Other recruiting trials for Central Line-associated Bloodstream Infection (CLABSI)
Currently open trials in the same condition.
- NCT06458231 — Determining the Prevalence of Primary and Secondary Central Line Associated Blood Stream Infection (CLABSI) at the Terti · recruiting
Other University of Zurich trials
Trials by the same sponsor.
- NCT07485699 — Soy Processing and Food Allergy · NA · not yet recruiting
- NCT07516912 — Evaluation of Free STI Testing Pilot Projects in Lucerne and Zurich, Switzerland · not yet recruiting
- NCT07473115 — Individualized Analgesia in the Intensive Care Unit With a New Pain Assessment Bundle and Protocolized Analgesia Adjustm · not yet recruiting
- NCT07524023 — Emotional-distress-based Integrated Care Programme in Patients With Stable COPD · NA · recruiting
- NCT06481982 — Value of Advanced MRI Techniques in the Assessment of Endometriosis · withdrawn
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04856878 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Zurich
- Last refreshed: 29 April 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04856878.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing